The development of an IgG lambda-type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on diphenylhydantoin (DILANTIN) therapy for 20 years is reported.
multiple myeloma
DILANTIN
multiple myeloma
diphenylhydantoin
IgG lambda-type monoclonal gammopathy
diphenylhydantoin
IgG lambda-type monoclonal gammopathy
DILANTIN